FDA should audit the Global Metrology Group. - Recensione dipendente - Meteorology Engineer presso AbbVie

1,0
10 gen 2023
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

My review is solely based on the Global Metrology Group. I think AbbVie outside of that Group is probably great. The benefits are amazing. Unfortunately new hires no longer get enrolled in the pension. The culture is very diverse friendly, and they treat their workers with the utmost respect. I used to be proud seeing our commercials come on TV. Made me proud!

Svantaggi

Over the 3 years I was with the company I witnessed numerous violations against AbbVie's' policies and FDA regulations. I constantly tried to change what was going on but Global Metrology Management didn't care. Violations Summary: (Elements of each as they relate to the Metrology program at AbbVie) Pharmaceuticals 21 CFR 211 Biologics 21 CFR 606 Medical Devices 21 CFR 820 Human Tissues 21 CFR 1271 Advice to potential Metrology candidate: The Global Metrology Group is highly resistive to change due to legacy Abbott employees and weak Management. If your work ethic is to follow Metrological standard's and be an agent for change, this place is not for you. I tried for 3 years and 10 months. I didn't leave because I was shown the door I left of my own volition.

Esplora altre recensioni su AbbVie

5,0
6 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great company culture and supportive team members

Svantaggi

No benefits as a contractor

4,0
8 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Not bad as pharma companies go. Relatively good job security. A lot of lovely, smart and hard working people. Benefits team are generally receptive and benefits have improved. Less likely to lay people off than other pharma/biotech.

Svantaggi

Your experience is almost entirely dictated by your managers. Adherence to official policies is super variable. Site is relatively siloed from the rest of the company, top-heavy, and academic. Too many PhDs, not enough entry level development to support projects and execution. Sometimes a lack of clear leadership or direction and bizarre "old school" pharma opaque communication. Very limited, once yearly opportunities for promotion. Bizarre pay /compensation penalties for taking parental leave that saddles two different calendar years.

3
Vedi recensioni per: Utile|Valutazione|Data|Tutto